US6952631033 - Common Stock

Taking everything into account, **PACW** scores **2** out of 10 in our fundamental rating. **PACW** was compared to 416 industry peers in the **Banks** industry. Both the profitability and financial health of **PACW** have multiple concerns. **PACW** has a valuation in line with the averages, but on the other hand it scores bad on growth.

Of the past 5 years **PACW** 4 years were profitable.

Each year in the past 5 years **PACW** had a positive operating cash flow.

The **Return On Assets** of **PACW** (**-3.27%**) is worse than **99.52%** of its industry peers.

With a **Return On Equity** value of **-49.51%**, **PACW** is not doing good in the industry: **99.52%** of the companies in the same industry are doing better.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -3.27% | ||

ROE | -49.51% | ||

ROIC | N/A |

ROA(3y)-0.59%

ROA(5y)0.35%

ROE(3y)-3.17%

ROE(5y)1.88%

ROIC(3y)N/A

ROIC(5y)N/A

The **Profit Margin** and **Operating Margin** and **Gross Margin** are not available for **PACW** so they could not be analyzed.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | N/A | ||

PM (TTM) | N/A | ||

GM | N/A |

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-10.15%

PM growth 5Y-1.85%

GM growth 3YN/A

GM growth 5YN/A

The number of shares outstanding for **PACW** remains at a similar level compared to 1 year ago.

Compared to 1 year ago, **PACW** has a worse debt to assets ratio.

The Debt to FCF ratio of **PACW** is **18.17**, which is on the high side as it means it would take **PACW**, **18.17** years of fcf income to pay off all of its debts.

Looking at the **Debt to FCF ratio**, with a value of **18.17**, **PACW** is doing worse than **83.93%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 2.85 | ||

Debt/FCF | 18.17 | ||

Altman-Z | N/A |

ROIC/WACCN/A

WACC11.75%

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | N/A | ||

Quick Ratio | N/A |

The earnings per share for **PACW** have decreased strongly by **-44.42%** in the last year.

The Revenue for **PACW** has decreased by **-23.40%** in the past year. This is quite bad

EPS 1Y (TTM)-44.42%

EPS 3Y-1.79%

EPS 5Y4.05%

EPS growth Q2Q-78.43%

Revenue 1Y (TTM)-23.4%

Revenue growth 3Y5.67%

Revenue growth 5Y4.27%

Revenue growth Q2Q-83.81%

The **Earnings Per Share** is expected to decrease by **-46.83%** on average over the next years. This is quite bad

EPS Next Y-87.54%

EPS Next 2Y-52.48%

EPS Next 3Y-46.83%

EPS Next 5YN/A

Revenue Next Year-45.69%

Revenue Next 2Y-18.18%

Revenue Next 3Y-16.73%

Revenue Next 5YN/A

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

With a **Price/Earnings** ratio of **3.13**, the valuation of **PACW** can be described as very cheap.

The average S&P500 **Price/Earnings** ratio is at **26.35**. **PACW** is valued rather cheaply when compared to this.

A **Price/Forward Earnings** ratio of **9.37** indicates a reasonable valuation of **PACW**.

Compared to the rest of the industry, the **Price/Forward Earnings** ratio of **PACW** indicates a somewhat cheap valuation: **PACW** is cheaper than 69.54% of the companies listed in the same industry.

Compared to an average S&P500 **Price/Forward Earnings** ratio of **21.63**, **PACW** is valued rather cheaply.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 3.13 | ||

Fwd PE | 9.37 |

Based on the **Price/Free Cash Flow** ratio, **PACW** is valued cheaper than 96.88% of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 2.25 | ||

EV/EBITDA | N/A |

A cheap valuation may be justified as **PACW**'s earnings are expected to decrease with **-46.83%** in the coming years.

PEG (NY)N/A

PEG (5Y)0.77

EPS Next 2Y-52.48%

EPS Next 3Y-46.83%

With a yearly dividend of 0.53%, **PACW** is not a good candidate for dividend investing.

Compared to an average industry **Dividend Yield** of **3.68**, **PACW**'s dividend is way lower than its industry peers. On top of this 86.57% of the companies listed in the same industry pay a better dividend than **PACW**!

Compared to an average S&P500 **Dividend Yield** of **2.46**, **PACW**'s dividend is way lower than the S&P500 average.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 0.53% |

The dividend of **PACW** decreases each year by **-10.10%**.

The dividend of **PACW** decreased recently.

Dividend Growth(5Y)-10.1%

Div Incr Years0

Div Non Decr Years1

The earnings of **PACW** are negative and hence is the payout ratio. **PACW** will probably not be able to sustain this dividend level.

The **Dividend Rate** of **PACW** has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.

DP-10.37%

EPS Next 2Y-52.48%

EPS Next 3Y-46.83%

**PACWEST BANCORP**

NASDAQ:PACW (11/30/2023, 7:16:12 PM)

After market: 7.6 +0.06 (+0.8%)**7.54**

**-0.21 (-2.71%) **

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupBanks

GICS IndustryBanks

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap894.17M

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 0.53% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 3.13 | ||

Fwd PE | 9.37 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)0.77

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -3.27% | ||

ROE | -49.51% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | N/A | ||

PM (TTM) | N/A | ||

GM | N/A | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.03

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 2.85 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | N/A | ||

Quick Ratio | N/A | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-44.42%

EPS 3Y-1.79%

EPS 5Y

EPS growth Q2Q

EPS Next Y-87.54%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-23.4%

Revenue growth 3Y5.67%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y